Type 2 Diabetes

>

Latest News

Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D | Image Credit: American Heart Association
Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D

November 16th 2024

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.

10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity
10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity

October 30th 2024

Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center
Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD

October 21st 2024

SGLT2i Outperforms DPP4i in Improving Hepatic Fibrosis Indices in T2D, MASLD| Image Credit: Markus Spiske/Unsplash
SGLT2i Outperforms DPP4i in Improving Hepatic Fibrosis Indices in MASLD

October 15th 2024

HCPLive Endocrinology Month in Review September 2024 thumbnail
Endocrinology Month in Review: September 2024

October 6th 2024

<1
...
130131132133134
© 2024 MJH Life Sciences

All rights reserved.